These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27384394)

  • 1. Non-target impurity profiling of marketplace Cetirizine using high-resolution mass spectrometry and multivariate data analysis.
    Zhou Z
    Rapid Commun Mass Spectrom; 2016 Sep; 30(17):1941-50. PubMed ID: 27384394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid simple approach to screening pharmaceutical products using ultra-performance LC coupled to time-of-flight mass spectrometry and pattern recognition.
    Plumb RS; Jones MD; Rainville PD; Nicholson JK
    J Chromatogr Sci; 2008 Mar; 46(3):193-8. PubMed ID: 18334084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted and untargeted screening for impurities in losartan tablets marketed in Germany by means of liquid chromatography/high resolution mass spectrometry.
    Backer L; Kinzig M; Sörgel F; Scherf-Clavel O; Holzgrabe U
    J Pharm Biomed Anal; 2024 Aug; 245():116160. PubMed ID: 38663256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated approach for detection and characterization of the trace impurities in levofloxacin using liquid chromatography-tandem mass spectrometry.
    Zheng YJ; He JM; Zhang RP; Wang YC; Wang JX; Wang HQ; Wu Y; He WY; Abliz Z
    Rapid Commun Mass Spectrom; 2014 May; 28(10):1164-74. PubMed ID: 24711279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of impurities of HIV NNRTI Doravirine by UHPLC-high resolution MS and tandem MS analysis.
    Zhang LK; Yang R; Sheng H; Helmy R; Zheng J; Cao Y; Gauthier DR
    J Mass Spectrom; 2016 Oct; 51(10):959-968. PubMed ID: 27383410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Impurity-Profiling Workflow with the Combination of Flash-Chromatography, UHPLC-MS, and Multivariate Data Analysis for Highly Pure Drugs: A Study on the Synthetic Cannabinoid MDMB-CHMICA.
    Münster-Müller S; Zimmermann R; Pütz M
    Anal Chem; 2018 Sep; 90(17):10559-10567. PubMed ID: 30079731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the structures of photodegradation impurities and pathways of photodegradation of cilnidipine by liquid chromatography/Q-Orbitrap mass spectrometry.
    Zeng H; Wang F; Zhu B; Zhong W; Shan W; Wang J
    Rapid Commun Mass Spectrom; 2016 Aug; 30(15):1771-8. PubMed ID: 27426453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impurity identification and quantification for arginine vasopressin by liquid chromatography/high-resolution mass spectrometry.
    Wu P; Ye S; Li M; Li H; Kan Y; Yang Z
    Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8799. PubMed ID: 32247289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and accurate quantification of structurally related peptide impurities in synthetic human C-peptide by liquid chromatography-high resolution mass spectrometry.
    Li M; Josephs RD; Daireaux A; Choteau T; Westwood S; Wielgosz RI; Li H
    Anal Bioanal Chem; 2018 Aug; 410(20):5059-5070. PubMed ID: 29862433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of impurity profiles of Orlistat pharmaceutical products using HPLC tandem mass spectrometry.
    Schneider A; Wessjohann LA
    J Pharm Biomed Anal; 2010 Nov; 53(3):767-72. PubMed ID: 20570457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the formation of bromhexine impurity E and its chromatographic behaviour.
    Venhuis BJ; Weda M; de Kaste D; Lamme EK
    Pharmeur Bio Sci Notes; 2012 Apr; 2012():135-41. PubMed ID: 23327897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of impurities in commercial spectinomycin by liquid chromatography with electrospray ionization tandem mass spectrometry.
    Wang Y; Wang M; Li J; Yao S; Xue J; Zou W; Hu C
    J Antibiot (Tokyo); 2014 Jul; 67(7):511-8. PubMed ID: 24736854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impurity profiling of liothyronine sodium by means of reversed phase HPLC, high resolution mass spectrometry, on-line H/D exchange and UV/Vis absorption.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Sep; 143():147-158. PubMed ID: 28599168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis and evaluation of the impurity of felodipine and its tablets].
    Zhang N; Yu LJ; Li J; Tong JW; Meng J; Zhang QM; Shi YQ
    Yao Xue Xue Bao; 2012 Feb; 47(2):223-8. PubMed ID: 22512035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyphenated liquid chromatography - diode array detection - charged aerosol detection - high resolution - multistage mass spectrometry with online hydrogen/deuterium exchange: One stop solution for pharmaceutical impurity profiling.
    Thakkar H; Jain S; Kumar S; Bhalekar VS; Gangakhedkar S; Shah RP
    J Chromatogr A; 2023 Jan; 1689():463725. PubMed ID: 36586282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate quantification of impurities in pure peptide material - angiotensin I: Comparison of calibration requirements and method performance characteristics of liquid chromatography coupled to hybrid tandem mass spectrometry and linear ion trap high-resolution mass spectrometry.
    Stoppacher N; Josephs RD; Daireaux A; Choteau T; Westwood S; Wielgosz RI
    Rapid Commun Mass Spectrom; 2015 Sep; 29(18):1651-60. PubMed ID: 26467117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impurity profiling of capreomycin using dual liquid chromatography coupled to mass spectrometry.
    Chopra S; Pendela M; Hoogmartens J; Van Schepdael A; Adams E
    Talanta; 2012 Oct; 100():113-22. PubMed ID: 23141318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levothyroxine sodium revisited: A wholistic structural elucidation approach of new impurities via HPLC-HRMS/MS, on-line H/D exchange, NMR spectroscopy and chemical synthesis.
    Ruggenthaler M; Grass J; Schuh W; Huber CG; Reischl RJ
    J Pharm Biomed Anal; 2017 Feb; 135():140-152. PubMed ID: 28024262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.